merck sales

    By Melly Alazraki

    | 8:00AM 7/30/2010
    Pharmaceutical giant Merck & Co. reported Friday its second-quarter net income fell 51% on higher restructuring and merger costs. But adjusted earnings beat analysts' estimates.